Light with clinical impact
A new standard in infection prevention
Lindo Life Science is redefining infection control by shifting healthcare processes from reactive treatment to continuous prevention at the source.
Our solutions embed infection prevention technology directly into healthcare systems, delivering autonomous, always-on disinfection across critical infection points.
Lindo Life Science’s patented antimicrobial blue light (aBL) technology delivers continuous, in-system disinfection across healthcare environments.
Designed to neutralise bacteria, viruses and biofilm at the source, our platform provides a safe, non-chemical alternative to traditional infection control methods.
Why it matters
Closing the gap in infection control
Healthcare-associated infections affect millions of patients globally each year, driven by rising antimicrobial resistance and fragmented infection control systems.
Current infection control systems are reactive, labour-intensive and dependent on chemicals.
Lindo’s technology shifts this model to continuous prevention, embedding protection directly into existing infrastructure.
Global TAM*
US$154B+
Global SAM*
US$26B+
Global SOM*
US$2.4B+
For workforce
- Address risk of infection
- Improve health, safety & wellbeing
- Do not disrupt workflow
For investors
- Versatile, scalable platform
- Secure IP
- Enable system-wide shift
For patients
- Improve comfort & wellbeing
- Enhance patient outcomes
- Fast-track recovery
For healthcare
- Protect patients & workforce
- Embed into existing infrastructure
- Reduce environmental impact
For facilities
- Autonomous, always-on disinfection
- Control contamination
- Reduce chemical use & manual labour
Stopping infection where it starts
The Lindo solution
Lindo Life Science delivers a scalable infection prevention platform that embeds antimicrobial protection directly into existing healthcare infrastructure.
By targeting bacteria at the source, our solutions reduce infection risk, minimise operational burden and support better patient outcomes.
- Continuous, always-on disinfection
- Non-chemical approach supporting antimicrobial resistance (AMR)
- Safe for clinical environments
- Effective against biofilm and drug-resistant bacteria
- Reduces reliance on manual cleaning processes
Lindo Drain
A retrofit-ready system that prevents contamination in drainage infrastructure, reducing biofilm-driven infection risk and eliminating reliance on manual cleaning processes.
Lindo Tube
A first-in-class antimicrobial endotracheal tube that delivers continuous protection within the airway, helping reduce ventilator-associated infections without disrupting clinical workflows.
Lindo Drain
A retrofit-ready system that prevents contamination in drainage infrastructure, reducing biofilm-driven infection risk and eliminating reliance on manual cleaning processes.
Lindo Tube
A first-in-class antimicrobial endotracheal tube that delivers continuous protection within the airway, helping reduce ventilator-associated infections without disrupting clinical workflows.
Scalable technology for real-world healthcare environments
At the core of every solution is Lindo’s patented antimicrobial blue light (aBL) technology.
This platform safely neutralises bacteria, viruses and biofilm within air, water and surfaces, delivering up to 99.99% reduction in pathogens while avoiding chemical use.
aBL technology is designed to integrate across multiple infection points within healthcare systems. From airways to drainage systems, the platform delivers consistent, scalable protection without disrupting existing workflows.
Our technology is:
- Retrofit-ready for existing infrastructure
- Designed for clinical integration
- Autonomous and low-maintenance
- Validated through industry and government partnerships
Patented multi-wavelength aBL technology inactivates bacteria, viruses and biofilm without chemicals
Single wavelength
Multi-wavelength
Frequently asked questions
What is aBL?
Antimicrobial blue light (aBL) operates in the visible spectrum (405–470nm) and has been shown to kill bacteria, mould and many viruses.
Lindo’s aBL technology enables measurable impact across:
- Clinical teams – reducing infection risk without disrupting care
- Healthcare operators – lowering cost and operational burden
- Facilities teams – delivering autonomous system-wide protection
- Patients – improving outcomes and recovery experiences
When was it discovered?
Disinfection with light has been researched and practised since the late 1800s. Multiple peer reviewed research papers have detailed the efficacy of aBL on pathogens such as staphylococcus, SARS-CoV-2 and Influenza A as well as airborne bacteria.
Lindo invests in and partners with global health institutions and research laboratories to contribute to the ever-growing empirical evidence base for aBL and translates insights into practical equipment and healthcare products.
Why choose aBL tech?
It is a versatile, non-chemical disinfection method that safely neutralises pathogens across air, water and surfaces, which can be a game-changer for healthcare and across multiple sectors.
With endless versatility and scalability, Lindo customises solutions that integrate aBL into LED fixtures to deliver smart, safe and fit-for-purpose disinfection systems.
Find out more about aBL in Lindo’s white paper – request here.
Can it reduce biofilm?
Yes, aBL has been shown to kill bacteria within biofilms, including multi-log reductions in key pathogens.
Can it reduce AMR?
aBL is a non-antibiotic approach, with studies showing no resistance development after repeated exposure cycles.
What other benefits are there?
The endless versatility of our automated disinfection systems improves the health and wellbeing of the environments where we live, work and heal in multiple ways. In addition to neutralising bacteria and viruses by up to 99.99% in the air, water and on surfaces, Lindo’s aBL solutions reduce resources, energy and chemical use by optimising the cleaning process. This also has a flow on effect to reducing rates of absenteeism in workplaces such as hospitals, aged care and childcare facilities.
Prevent infection at the source
Lindo Life Science is building a scalable platform capable of transforming infection prevention globally.
By embedding protection directly into healthcare systems, we enable a fundamental shift from treatment to prevention, improving patient outcomes and supporting a more efficient and sustainable model of care.